Kazem Nasserinejad

5PUBLICATIONS
31CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Statistical theoryPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2026
Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.

Febe Smits, Kaz Groen, Charlotte L B M Korst

|Aug 19, 2024
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.

Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart

|May 24, 2023
Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness.

Rebecca A Hermans, Sebastiaan D T Sassen, Sanne Maartje Kloosterboer

|Aug 13, 2021
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.

Marie José Kersten, Karima Amaador, Monique C Minnema

|May 04, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek

Pageof 1

Frequent Collaborators

2 joint publications

Lidwine W Tick

2 joint publications

Pieter Sonneveld

2 joint publications

Monique C Minnema

2 joint publications

Sonja Zweegman